Sabrina Cencig
Overview
Explore the profile of Sabrina Cencig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Radwanska M, de Lemos Esteves F, Linsen L, Coltel N, Cencig S, Widart J, et al.
Front Immunol
. 2023 Apr;
14:1138526.
PMID: 37033946
This work identifies the protein "macrophage infectivity potentiator" of trypomastigotes, as supporting a new property, namely a pro-type 1 immunostimulatory activity on neonatal cells. In its recombinant form (rTcMIP), this...
2.
Filtjens J, Coltel N, Cencig S, Taveirne S, Van Ammel E, Van Acker A, et al.
Front Immunol
. 2016 Nov;
7:472.
PMID: 27891126
The protozoan parasite circulates in the blood upon infection and invades various cells. Parasites intensively multiply during the acute phase of infection and persist lifelong at low levels in tissues...
3.
Cencig S, Coltel N, Truyens C, Carlier Y
PLoS Negl Trop Dis
. 2013 Jun;
7(6):e2271.
PMID: 23785533
This work aims to compare the effects of acute or chronic infections with the T. cruzi genotypes TcI (X10 strain), TcII (Y strain) and TcVI (Tulahuen strain) on fertility, gestation,...
4.
Cencig S, Coltel N, Truyens C, Carlier Y
Int J Antimicrob Agents
. 2012 Oct;
40(6):527-32.
PMID: 23063742
The present work aimed to investigate the curative effect of benznidazole (BZL) in combination with other patented drugs [nifurtimox (NFX), posaconazole (POS) or AmBisome(®) (AMB)] in mice acutely or chronically...
5.
Cencig S, Coltel N, Truyens C, Carlier Y
PLoS Negl Trop Dis
. 2011 Jul;
5(6):e1216.
PMID: 21738811
Background: Chagas disease is one of the most important public health problems and a leading cause of cardiac failure in Latin America. The currently available drugs to treat T. cruzi...
6.
Rossato M, Cencig S, Gasperini S, Cassatella M, Bazzoni F
Eur J Immunol
. 2007 Oct;
37(11):3176-89.
PMID: 17948269
We have recently reported that the ability of IL-10 to rapidly exert its anti-inflammatory effects on human neutrophils is dependent upon exposure of these cells to LPS for at least...
7.
Cencig S, Nanbru C, Le S, Gueydan C, Huez G, Kruys V
Oncogene
. 2004 Jan;
23(1):267-77.
PMID: 14712232
The human c-myc proto-oncogene is transcribed from four alternative promoters generating transcripts with 5' untranslated regions of various lengths. These transcripts encode two proteins, c-Myc1 and c-Myc2, from two initiation...